NCT00891267

Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome

Effect of Olmesartan Medoxomil on Vascular Markers in Hypertensive Patients With Metabolic Syndrome

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to study the effect of two doses of olmesartan medoxomil and amlodipine on vascular markers in hypertensive patients with metabolic syndrome.

Conditions

• Metabolic Syndrome
• Hypertension

Interventions

Type	Name	Description
DRUG	Olmesartan medoxomil tablets low dose	Olmesartan medoxomil tablets low dose, taken once daily for 6 weeks
DRUG	Olmesartan medoxomil tablets high dose	Olmesartan medoxomil tablets high dose, taken once daily for 6 weeks
DRUG	Amlodipine	Amlodipine tablets taken once daily for 6 weeks

Timeline

• Start date: 2008-10-01
• Primary completion: 2011-04-01
• Completion: 2011-05-01
• First posted: 2009-05-01
• Last updated: 2018-12-24

Locations

1 site across 1 country: Germany